Cancer Research and Treatment

The Korean Cancer Association (대한암학회)
권호 표지
DOI QR코드

DOI QR Code

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

  • Jung, Kyu-Won (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Park, So-Hee (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Kong, Hyun-Joo (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Won, Young-Joo (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Lee, Joo-Young (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center) ;
  • Park, Eun-Cheol (National Cancer Control Institute, National Cancer Center) ;
  • Lee, Jin-Soo (The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center)
  • Published : 2011.03.30
⟨ Previous Next ⟩

Abstract

Purpose: This paper overviews the nationwide cancer statistics including incidence, mortality, survival and prevalence, and their trends in Korea based on the year 2008 cancer incidence data. Materials and Methods: Incidence data from 1993 to 2008 were obtained from the Korea National Cancer Incidence Database, and the vital status was followed through December 31, 2009. Mortality data from 1983 to 2008 were obtained from the Korea National Statistics Office. Crude rates and age-standardized rates for incidence, mortality, prevalence and relative survival were calculated. Results: There were 178,816 cancer cases and 68,912 cancer deaths observed during year 2008 and 724,663 10-year cancer prevalent cases as of January 1, 2009 in Korea. The incidence rate for all cancer combined showed an annual increase of 3.1% from 1999 to 2008. Conclusion: With significantly increasing cancer incidence, Korea faces a large cancer burden and efficient cancer control programs are essential.

Keywords

References

  1. National Statistical Office, 2009 [Internet]. Daejeon: National Statistical Office; 2009 [cited 2011 Jan 14]. Available from: http://kostat.go.kr .
  2. Ministry for Heath, Welfare and Family Affairs. Annual report of cancer incidence (2006) and survival (1993-2006) in Korea. Seoul: Ministry for Heath, Welfare and Family Affairs; 2009.
  3. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009;41:122-31. https://doi.org/10.4143/crt.2009.41.3.122
  4. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999-2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325-31. https://doi.org/10.4143/crt.2005.37.6.325
  5. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
  6. World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death. 10th rev. Geneva: World Health Organization; 1992.
  7. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.
  8. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W. SEER cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
  9. National Cancer Institute. $SEER^{\ast}Stat$ Program, version 6.6.1 [Internet]. Bethsda, MD: National Cancer Institute; 2011 [cited 2011 Jan 14]. Available from: http://seer. cancer.gov/seerstat/.
  10. Ederer F, Heise H. Instructions to IBM programmers in processing survival computations. Methodological note No. 10. Bethesda, MD: National Cancer Institute; 1959.
  11. Dickman P [Internet]. Stockholm: PaulDickman.com [cited 2009 Apr 14]. Available from: http//www.pauldickman.com.
  12. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-7. https://doi.org/10.1001/jama.295.18.2164
  13. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18:784-91. https://doi.org/10.1158/1055-9965.EPI-08-0960
  14. Curado MP, Edwards B, Shin HR, Stom H, Ferlay J, Heanue M. Cancer incidence in five continents, vol . 9. Lyon: IARC; 2007.
  15. Jung KW, Yim SH, Kong HJ, Hwang SY, Won YJ, Lee JK, et al. Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci. 2007;22(Suppl):S5-10. https://doi.org/10.3346/jkms.2007.22.S.S5
  16. Gondos A, Bray F, Hakulinen T, Brenner H. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol. 2009;20:564-73.
  17. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103-17. https://doi.org/10.1111/j.1365-2796.2006.01677.x

Cited by

  1. Alternative Medical Treatment for Radioiodine-Refractory Thyroid Cancers vol.45, pp.4, 2011, https://doi.org/10.1007/s13139-011-0107-7
  2. Risk Factors and Control Strategies for the Rapidly Rising Rate of Breast Cancer in Korea vol.14, pp.2, 2011, https://doi.org/10.4048/jbc.2011.14.2.79
  3. Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer vol.27, pp.3, 2011, https://doi.org/10.3393/jksc.2011.27.3.140
  4. Pulmonary Metastasis from Rectal Cancer on Chest CT Is Correlated with 3T MRI Primary Tumor Location vol.65, pp.2, 2011, https://doi.org/10.3348/jksr.2011.65.2.151
  5. Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2010 vol.43, pp.3, 2011, https://doi.org/10.4143/crt.2011.43.3.141
  6. Gastric Cancer Epidemiology in Korea vol.11, pp.3, 2011, https://doi.org/10.5230/jgc.2011.11.3.135
  7. Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis vol.43, pp.4, 2011, https://doi.org/10.4143/crt.2011.43.4.217
  8. A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis vol.43, pp.4, 2011, https://doi.org/10.4143/crt.2011.43.4.225
  9. Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer vol.43, pp.4, 2011, https://doi.org/10.4143/crt.2011.43.4.236
  10. Nutritional Consequences and Management After Gastrectomy vol.31, pp.4, 2011, https://doi.org/10.7599/hmr.2011.31.4.254
  11. Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer vol.27, pp.6, 2011, https://doi.org/10.3393/jksc.2011.27.6.322
  12. Aging over 70 Years Is Not a Decisively Dismal Prognostic Factor in Gastric Cancer Surgery vol.11, pp.4, 2011, https://doi.org/10.5230/jgc.2011.11.4.200
  13. 한국 공군 공중근무자 암 발생 조사 vol.19, pp.4, 2011, https://doi.org/10.12985/ksaa.2011.19.4.099
  14. Retrospective analysis of treatment outcomes after postoperative chemoradiotherapy in advanced gastric cancer vol.29, pp.4, 2011, https://doi.org/10.3857/roj.2011.29.4.252
  15. Surgical stress after robot‐assisted distal gastrectomy and its economic implications vol.99, pp.11, 2011, https://doi.org/10.1002/bjs.8887
  16. Value of Surveillance $^{18}F$-FDG PET/CT in Colorectal Cancer: Comparison with Conventional Imaging Studies vol.46, pp.3, 2011, https://doi.org/10.1007/s13139-012-0145-9
  17. Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patients vol.23, pp.8, 2011, https://doi.org/10.1093/annonc/mdr606
  18. Laparoscopic Compared With Open Radical Hysterectomy in Obese Women With Early-Stage Cervical Cancer : vol.119, pp.6, 2011, https://doi.org/10.1097/aog.0b013e318256ccc5
  19. RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin vol.35, pp.11, 2012, https://doi.org/10.1159/000343636
  20. Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival vol.12, pp.None, 2011, https://doi.org/10.1186/1471-2407-12-195
  21. Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer vol.12, pp.None, 2011, https://doi.org/10.1186/1471-2407-12-347
  22. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study vol.12, pp.None, 2012, https://doi.org/10.1186/1471-2407-12-452
  23. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer vol.17, pp.3, 2011, https://doi.org/10.3109/1354750x.2012.656705
  24. Current Management and Future Strategies of Gastric Cancer vol.53, pp.2, 2011, https://doi.org/10.3349/ymj.2012.53.2.248
  25. Impact of Clinicopathologic Factors on Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma vol.53, pp.5, 2012, https://doi.org/10.3349/ymj.2012.53.5.924
  26. Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer vol.41, pp.2, 2011, https://doi.org/10.3892/ijo.2012.1470
  27. Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status vol.3, pp.2, 2011, https://doi.org/10.3892/ol.2011.496
  28. Irinotecan, leucovorin and 5-fluorouracil (modified FOLFIRI) as salvage chemotherapy for frail or elderly patients with advanced gastric cancer vol.4, pp.4, 2012, https://doi.org/10.3892/ol.2012.782
  29. Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea vol.53, pp.10, 2011, https://doi.org/10.4111/kju.2012.53.10.680
  30. Clinical Experience with Limited Lymph Node Dissection for Prostate Cancer in Korea: Single Center Comparison of 247 Open and 354 Robot-Assisted Laparoscopic Radical Prostatectomy Series vol.53, pp.11, 2011, https://doi.org/10.4111/kju.2012.53.11.755
  31. Current Status of Targeted Therapy for Advanced Renal Cell Carcinoma vol.53, pp.4, 2011, https://doi.org/10.4111/kju.2012.53.4.217
  32. Differences in Postoperative Pathological Outcomes between Prostate Cancers Diagnosed at Initial and Repeat Biopsy vol.53, pp.8, 2011, https://doi.org/10.4111/kju.2012.53.8.531
  33. Korean Guidelines for Colorectal Cancer Screening and Polyp Detection vol.59, pp.2, 2012, https://doi.org/10.4166/kjg.2012.59.2.65
  34. Prognostic Significance of the Lymph Node Ratio Regarding Recurrence and Survival in Rectal Cancer Patients Treated with Postoperative Chemoradiotherapy vol.6, pp.2, 2011, https://doi.org/10.5009/gnl.2012.6.2.203
  35. Prostate Stem Cell Antigen Single Nucleotide Polymorphisms Influence Risk of Estrogen Receptor Negative Breast Cancer in Korean Females vol.13, pp.1, 2011, https://doi.org/10.7314/apjcp.2012.13.1.041
  36. Awareness and Practice of Breast Self-examination among Korean Women: Results from a Nationwide Survey vol.13, pp.1, 2011, https://doi.org/10.7314/apjcp.2012.13.1.123
  37. Korean Guidelines for Colorectal Cancer Screening and Polyp Detection vol.10, pp.1, 2011, https://doi.org/10.5217/ir.2012.10.1.67
  38. Korean Guidelines for Colorectal Cancer Screening and Polyp Detection vol.45, pp.1, 2011, https://doi.org/10.5946/ce.2012.45.1.25
  39. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009 vol.44, pp.1, 2011, https://doi.org/10.4143/crt.2012.44.1.11
  40. Current status of the National Cancer Screening Program for cervical cancer in Korea, 2009 vol.23, pp.1, 2012, https://doi.org/10.3802/jgo.2012.23.1.16
  41. The premier statistical report of hematologic malignancies in Korea vol.47, pp.1, 2011, https://doi.org/10.5045/kjh.2012.47.1.1
  42. Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008 vol.47, pp.1, 2011, https://doi.org/10.5045/kjh.2012.47.1.28
  43. Treatment outcome in patients with vulvar cancer: comparison of concurrent radiotherapy to postoperative radiotherapy vol.30, pp.1, 2011, https://doi.org/10.3857/roj.2012.30.1.20
  44. Relationship between Positron Emission Tomography Uptake and Macroscopic Findings of Colorectal Cancer vol.10, pp.2, 2012, https://doi.org/10.5217/ir.2012.10.2.168
  45. Korean Guidelines for Colorectal Cancer Screening and Polyp Detection vol.66, pp.4, 2011, https://doi.org/10.3348/jksr.2012.66.4.385
  46. Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum vol.106, pp.9, 2011, https://doi.org/10.1038/bjc.2012.100
  47. Surgical outcomes and prognostic factors influencing long-term survival in patients with gallbladder cancer vol.16, pp.2, 2011, https://doi.org/10.14701/kjhbps.2012.16.2.59
  48. Review of Molecular Markers for Thyroid Cancer vol.35, pp.1, 2011, https://doi.org/10.12771/emj.2012.35.1.3
  49. Proposal for Creating a Guideline for Cancer Registration of Microinvasive Tumors of the Breast and Ovary (II) vol.46, pp.3, 2012, https://doi.org/10.4132/koreanjpathol.2012.46.3.226
  50. Amplification of the UQCRFS1 Gene in Gastric Cancers vol.12, pp.2, 2011, https://doi.org/10.5230/jgc.2012.12.2.73
  51. 일부 여대생에서 인유두종 바이러스 예방접종과 관련요인 vol.16, pp.2, 2011, https://doi.org/10.21896/jksmch.2012.16.2.186
  52. Adjuvant Chemotherapy With or Without Pelvic Radiotherapy After Simultaneous Surgical Resection of Rectal Cancer With Liver Metastases: Analysis of Prognosis and Patterns of Recurrence vol.84, pp.1, 2011, https://doi.org/10.1016/j.ijrobp.2011.10.070
  53. Adjuvant Chemotherapy and Survival of Elderly Korean Patients with Breast Carcinoma vol.15, pp.3, 2011, https://doi.org/10.4048/jbc.2012.15.3.296
  54. Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma vol.15, pp.3, 2011, https://doi.org/10.4048/jbc.2012.15.3.313
  55. Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer vol.70, pp.4, 2011, https://doi.org/10.1007/s00280-012-1935-6
  56. Discovery and Evaluation of Polymorphisms in the AKT2 and AKT3 Promoter Regions for Risk of Korean Lung Cancer vol.10, pp.3, 2011, https://doi.org/10.5808/gi.2012.10.3.167
  57. Oncologic Outcome After Preoperative Chemoradiotherapy in Patients With Pathologic T0 (ypT0) Rectal Cancer vol.55, pp.10, 2011, https://doi.org/10.1097/dcr.0b013e3182644334
  58. Safety and Efficacy of Fast-track Surgery in Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Clinical Trial vol.36, pp.12, 2011, https://doi.org/10.1007/s00268-012-1741-7
  59. Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer vol.23, pp.4, 2011, https://doi.org/10.3802/jgo.2012.23.4.226
  60. Prognostic Relevance of the Expression of CA IX, GLUT-1, and VEGF in Ovarian Epithelial Cancers vol.46, pp.6, 2011, https://doi.org/10.4132/koreanjpathol.2012.46.6.532
  61. Plasma human mammaglobin mRNA associated with poor outcome in patients with breast cancer vol.11, pp.4, 2012, https://doi.org/10.4238/2012.november.28.2
  62. Global estimates of cancer prevalence for 27 sites in the adult population in 2008 vol.132, pp.5, 2011, https://doi.org/10.1002/ijc.27711
  63. Laparoscopic versus open radical hysterectomy in patients with stage IB2 and IIA2 cervical cancer vol.108, pp.1, 2011, https://doi.org/10.1002/jso.23347
  64. Diagnostic Accuracy of the Ultrasonographic Features for Subcentimeter Thyroid Nodules Suggested by the Revised American Thyroid Association Guidelines vol.23, pp.12, 2011, https://doi.org/10.1089/thy.2012.0586
  65. Health Behaviors of Cancer Survivors: The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV, 2007–09) vol.43, pp.10, 2013, https://doi.org/10.1093/jjco/hyt118
  66. Commentary: the association between low‐dose aspirin use and the incidence of colorectal cancer vol.38, pp.6, 2011, https://doi.org/10.1111/apt.12437
  67. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy vol.13, pp.None, 2011, https://doi.org/10.1186/1471-2407-13-350
  68. The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer vol.13, pp.None, 2011, https://doi.org/10.1186/1471-2407-13-43
  69. The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registration vol.8, pp.None, 2011, https://doi.org/10.1186/1748-717x-8-104
  70. Lateral Topography for Reducing Effective Dose in Low-Dose Chest CT vol.200, pp.6, 2011, https://doi.org/10.2214/ajr.12.9001
  71. A Multicenter Retrospective Analysis of the Clinical Features of Pernicious Anemia in a Korean Population vol.28, pp.2, 2011, https://doi.org/10.3346/jkms.2013.28.2.200
  72. Disability Weights for Cancers in Korea vol.28, pp.6, 2011, https://doi.org/10.3346/jkms.2013.28.6.808
  73. Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor vol.28, pp.7, 2011, https://doi.org/10.3346/jkms.2013.28.7.1005
  74. Ground-Glass Opacity in Lung Metastasis from Breast Cancer: A Case Report vol.74, pp.1, 2013, https://doi.org/10.4046/trd.2013.74.1.32
  75. A Case of Atypical Adenomatous Hyperplasia of Larger Than 2 cm vol.74, pp.6, 2011, https://doi.org/10.4046/trd.2013.74.6.280
  76. Clinical Features and Prognostic Factors in Elderly Koreans with Advanced Non-Small-Cell Lung Cancer in a Tertiary Referral Hospital vol.75, pp.2, 2011, https://doi.org/10.4046/trd.2013.75.2.52
  77. Expression of Heat Shock Protein 70 Modulates the Chemoresponsiveness of Pancreatic Cancer vol.7, pp.6, 2013, https://doi.org/10.5009/gnl.2013.7.6.739
  78. Expression of Multidrug Resistance-Associated Protein 2 in Human Gallbladder Carcinoma vol.2013, pp.None, 2011, https://doi.org/10.1155/2013/527534
  79. Connexin32 inhibits gastric carcinogenesis through cell cycle arrest and altered expression of p21Cip1 and p27Kip1 vol.46, pp.1, 2011, https://doi.org/10.5483/bmbrep.2013.46.1.078
  80. The Iatrogenic Complications of Colonoscopic Polypectomy: A Multicenter Retrospective Study vol.11, pp.1, 2011, https://doi.org/10.5217/ir.2013.11.1.46
  81. Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients vol.16, pp.1, 2011, https://doi.org/10.4048/jbc.2013.16.1.97
  82. Outcomes of Laparoscopic Gastrectomy after Endoscopic Treatment for Gastric Cancer: A Comparison with Open Gastrectomy vol.13, pp.1, 2011, https://doi.org/10.5230/jgc.2013.13.1.51
  83. Prevalence of the Metabolic Syndrome and Associated Factors in Korean Cancer Survivors vol.14, pp.3, 2011, https://doi.org/10.7314/apjcp.2013.14.3.1773
  84. Prognostic Significance of Serum Levels of Vascular Endothelial Growth Factor and Insulin-Like Growth Factor-1 in Advanced Gastric Cancer Patients Treated with FOLFOX Chemotherapy vol.58, pp.6, 2011, https://doi.org/10.1159/000345918
  85. Nutritional Assessment and Perioperative Nutritional Support in Gastric Cancer Patients vol.61, pp.4, 2011, https://doi.org/10.4166/kjg.2013.61.4.186
  86. Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population vol.16, pp.2, 2011, https://doi.org/10.1007/s10120-012-0176-z
  87. 부산지역을 중심으로 조사된 암환자의 방사선 치료 현황 vol.7, pp.2, 2011, https://doi.org/10.7742/jksr.2013.7.2.151
  88. Body Mass Index as a Predictor of Advanced Colorectal Neoplasia vol.18, pp.2, 2011, https://doi.org/10.15430/jcp.2013.18.2.144
  89. Antiadhesive effect and safety of oxidized regenerated cellulose after thyroidectomy: a prospective, randomized controlled study vol.84, pp.6, 2011, https://doi.org/10.4174/jkss.2013.84.6.321
  90. Predicting Survival in Patients with Advanced Non-squamous Non-small Cell Lung Cancer: Validating the Extent of Metastasis vol.45, pp.2, 2011, https://doi.org/10.4143/crt.2013.45.2.95
  91. Prevalence and Risk Factors of Colorectal Adenoma in 14,932 Koreans Undergoing Screening Colonoscopy vol.62, pp.2, 2011, https://doi.org/10.4166/kjg.2013.62.2.104
  92. Optimal Time of Initiating Adjuvant Chemotherapy After Curative Surgery in Colorectal Cancer Patients vol.29, pp.4, 2011, https://doi.org/10.3393/ac.2013.29.4.150
  93. Prevalence of and Factors Associated with Osteoporosis among Korean Cancer Survivors: A Cross-Sectional Analysis of the Fourth and Fifth Korea National Health and Nutrition Examination Surveys vol.14, pp.8, 2011, https://doi.org/10.7314/apjcp.2013.14.8.4743
  94. Effects of matrine on the proliferation of HT29 human colon cancer cells and its antitumor mechanism vol.6, pp.3, 2011, https://doi.org/10.3892/ol.2013.1449
  95. Prognostic Significance of Serum Carcinoembryonic Antigen Normalization on Survival in Rectal Cancer Treated with Preoperative Chemoradiation vol.45, pp.3, 2013, https://doi.org/10.4143/crt.2013.45.3.186
  96. Clinical Significance and Long-Term Outcome of Incidentally Found Bile Duct Dilatation vol.58, pp.11, 2011, https://doi.org/10.1007/s10620-013-2792-9
  97. Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to p vol.16, pp.4, 2011, https://doi.org/10.1007/s10120-012-0227-5
  98. Association of the miR‐146aC>G, miR‐149T>C, miR‐196a2T>C, and miR‐499A>G polymorphisms with gastric cancer risk and survival in the korean population vol.52, pp.1, 2011, https://doi.org/10.1002/mc.21962
  99. Validity of Fecal Occult Blood Test in the National Cancer Screening Program, Korea vol.8, pp.11, 2011, https://doi.org/10.1371/journal.pone.0079292
  100. Hazard of Recurrence after Breast Surgery according to Hormone Receptor Status and Age vol.1, pp.1, 2011, https://doi.org/10.14449/jbd.2013.1.10
  101. Prioritization of Research Topics of Korean Oncology Nurses vol.13, pp.4, 2011, https://doi.org/10.5388/aon.2013.13.4.295
  102. Prevalence, Awareness, Control, and Treatment of Hypertension and Diabetes in Korean Cancer Survivors: A Cross-Sectional Analysis of the Fourth and Fifth Korea National Health and Nutrition Examinatio vol.14, pp.12, 2011, https://doi.org/10.7314/apjcp.2013.14.12.7685
  103. Toxicity and quality of life of Korean breast cancer patients treated with docetaxel-containing chemotherapy without primary G-CSF prophylaxis vol.21, pp.6, 2011, https://doi.org/10.1007/s12282-013-0442-x
  104. Do newly built homes affect rhinitis in children? The ISAAC phase III study in Korea vol.69, pp.4, 2011, https://doi.org/10.1111/all.12355
  105. Ischemic Stroke in Patients with Cancer: Is it Different from Usual Strokes? vol.9, pp.4, 2011, https://doi.org/10.1111/ijs.12124
  106. Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients vol.2014, pp.None, 2011, https://doi.org/10.1155/2014/370825
  107. Attributable fraction of alcohol consumption on cancer using population-based nationwide cancer incidence and mortality data in the Republic of Korea vol.14, pp.None, 2011, https://doi.org/10.1186/1471-2407-14-420
  108. Influenza Vaccination and Associated Factors among Korean Cancer Survivors : A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys vol.29, pp.8, 2011, https://doi.org/10.3346/jkms.2014.29.8.1061
  109. Prognosis of Prostate Cancer With Other Primary Malignancies vol.55, pp.5, 2011, https://doi.org/10.4111/kju.2014.55.5.327
  110. Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment vol.46, pp.2, 2011, https://doi.org/10.4143/crt.2014.46.2.172
  111. Preclinical Efficacy Testing for Stomach and Liver Cancers vol.46, pp.2, 2014, https://doi.org/10.4143/crt.2014.46.2.186
  112. Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer vol.73, pp.1, 2011, https://doi.org/10.1007/s00280-013-2340-5
  113. Prognostic Impact of Microscopic Tumor Involved Resection Margin in Advanced Gastric Cancer Patients after Gastric Resection vol.38, pp.2, 2011, https://doi.org/10.1007/s00268-013-2301-5
  114. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema vol.108, pp.3, 2011, https://doi.org/10.1016/j.rmed.2013.11.013
  115. The availability of computed tomography for pulmonary staging in colorectal cancer vol.86, pp.4, 2014, https://doi.org/10.4174/astr.2014.86.4.212
  116. Low C24‐OH and C22‐OH sulfatides in human renal cell carcinoma vol.49, pp.5, 2011, https://doi.org/10.1002/jms.3358
  117. Comprehension of readmission after laparoscopy assisted distal gastrectomy: what are the causes? vol.86, pp.5, 2011, https://doi.org/10.4174/astr.2014.86.5.237
  118. Burden of disease in Korea during 2000–10 vol.36, pp.2, 2014, https://doi.org/10.1093/pubmed/fdt056
  119. Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study vol.32, pp.19, 2014, https://doi.org/10.1200/jco.2013.53.6136
  120. Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer vol.4, pp.None, 2011, https://doi.org/10.1038/srep07592
  121. Combined Effects of Smoking and Bilirubin Levels on the Risk of Lung Cancer in Korea: The Severance Cohort Study vol.9, pp.8, 2014, https://doi.org/10.1371/journal.pone.0103972
  122. Clinical Characteristics of Long-Term Survivors of Inoperable Pancreatic Cancer: An 8-Year Cohort Analysis in Korea vol.43, pp.7, 2011, https://doi.org/10.1097/mpa.0000000000000163
  123. Doxorubicin에 의한 내인성 산화질소가 인간 대장암 세포주에서의 세포사멸에 미치는 효과 vol.24, pp.10, 2011, https://doi.org/10.5352/jls.2014.24.10.1137
  124. Colon Cancer Screening with Image-Enhanced Endoscopy vol.47, pp.6, 2011, https://doi.org/10.5946/ce.2014.47.6.504
  125. Risk Factors for Distant Metastasis as a Primary Site of Treatment Failure in Early-Stage Breast Cancer vol.50, pp.3, 2011, https://doi.org/10.4068/cmj.2014.50.3.96
  126. 유방절제술 환자가 지각한 배우자 지지와 건강증진 행위의 관계 vol.14, pp.4, 2014, https://doi.org/10.5388/aon.2014.14.4.203
  127. Computational Discrimination of Breast Cancer for Korean Women Based on Epidemiologic Data Only vol.30, pp.8, 2011, https://doi.org/10.3346/jkms.2015.30.8.1025
  128. Gene-gene interaction analysis identifies a new genetic risk factor for colorectal cancer vol.22, pp.1, 2011, https://doi.org/10.1186/s12929-015-0180-9
  129. Incidence of Primary Spinal Cord, Spinal Meninges, and Cauda Equina Tumors in Korea, 2006-2010 vol.47, pp.2, 2011, https://doi.org/10.4143/crt.2014.017
  130. Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy vol.22, pp.6, 2015, https://doi.org/10.1245/s10434-014-4168-6
  131. Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion vol.20, pp.6, 2011, https://doi.org/10.1634/theoncologist.2014-0459
  132. Incidence of kidney, bladder, and prostate cancers in Korea: An update vol.56, pp.6, 2011, https://doi.org/10.4111/kju.2015.56.6.422
  133. APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer vol.47, pp.4, 2015, https://doi.org/10.4143/crt.2014.074
  134. IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06) vol.192, pp.6, 2011, https://doi.org/10.1007/s00066-016-0959-y
  135. Hazard Ratio of Smoking on Lung Cancer in Korea According to Histological Type and Gender vol.194, pp.2, 2016, https://doi.org/10.1007/s00408-015-9836-1
  136. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker vol.2016, pp.None, 2016, https://doi.org/10.1155/2016/7276502
  137. Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02) vol.7, pp.6, 2016, https://doi.org/10.18632/oncotarget.6874
  138. Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer vol.9, pp.None, 2011, https://doi.org/10.2147/ott.s108787
  139. Laparoscopic gastric cancer surgery: Current evidence and future perspectives vol.22, pp.2, 2016, https://doi.org/10.3748/wjg.v22.i2.727
  140. Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer vol.20, pp.1, 2011, https://doi.org/10.5213/inj.1632600.300
  141. A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non–Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib vol.22, pp.9, 2011, https://doi.org/10.1158/1078-0432.ccr-15-1653
  142. Surgical management of extra-regional lymph node metastasis in colorectal cancer vol.16, pp.5, 2011, https://doi.org/10.1586/14737140.2016.1162718
  143. Breast Cancer Detection Rate, Incidence, Prevalence and Interval Cancer-related Mammography Screening Times among Thai Women vol.17, pp.8, 2011, https://doi.org/10.14456/apjcp.2016.227/apjcp.2016.17.8.4137
  144. Cholecystokinin as a potent diagnostic marker for gastric cancer vol.11, pp.1, 2011, https://doi.org/10.1007/s13206-016-1103-x
  145. Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer vol.11, pp.5, 2017, https://doi.org/10.5009/gnl16526
  146. Is Endoscopic Resection Really Safe for Mucosal Gastric Cancers? vol.17, pp.1, 2011, https://doi.org/10.7704/kjhugr.2017.17.1.56
  147. Vulvar cancer in Tunisia: Epidemiological and clinicopathological features multicentric study vol.29, pp.2, 2017, https://doi.org/10.1016/j.jnci.2017.02.001
  148. Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract vol.11, pp.1, 2011, https://doi.org/10.1016/j.tranon.2017.10.008
  149. A Survey of Radiation Therapy Utilization in Korea from 2010 to 2016: Focusing on Use of Intensity-Modulated Radiation Therapy vol.33, pp.9, 2018, https://doi.org/10.3346/jkms.2018.33.e67
  150. Thirty‐five years of single surgeon experience in the reconstruction of esophagus and voice with free ileocolon flap following total pharyngolaryngectomy vol.117, pp.3, 2011, https://doi.org/10.1002/jso.24864
  151. Instrumentation Failure after Partial Corpectomy with Instrumentation of a Metastatic Spine vol.61, pp.3, 2011, https://doi.org/10.3340/jkns.2017.0505.002
  152. Cancer in thyroid nodules with fine-needle aspiration in Korean pediatric populations vol.23, pp.2, 2011, https://doi.org/10.6065/apem.2018.23.2.94
  153. l-carnosine induces apoptosis/cell cycle arrest via suppression of NF-κB/STAT1 pathway in HCT116 colorectal cancer cells vol.54, pp.7, 2011, https://doi.org/10.1007/s11626-018-0264-4
  154. Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma vol.18, pp.None, 2018, https://doi.org/10.1186/s12894-018-0380-1
  155. Study of Gene Expression Profiles of Breast Cancers in Indian Women vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-019-46261-1
  156. Complications Following Colonoscopy in a Nationwide Standard Cohort: A Retrospective Case-control Study vol.73, pp.3, 2019, https://doi.org/10.4166/kjg.2019.73.3.152
  157. Performance Evaluation of SENTiFIT 270 and FOB Gold Reagent for Detecting Fecal Occult Blood vol.22, pp.2, 2011, https://doi.org/10.5145/acm.2019.22.2.29
  158. Potentially modifiable blood triglyceride levels by the control of conventional risk factors vol.18, pp.1, 2011, https://doi.org/10.1186/s12944-019-1134-0
  159. Deep Learning in Thyroid Ultrasonography to Predict Tumor Recurrence in Thyroid Cancers vol.81, pp.5, 2011, https://doi.org/10.3348/jksr.2019.0147
  160. Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis vol.86, pp.1, 2011, https://doi.org/10.5334/aogh.2607
  161. Implications of Radiotherapy Utilization in Korea from 2010 to 2019 vol.36, pp.18, 2021, https://doi.org/10.3346/jkms.2021.36.e117
  162. Cohort profile: National Investigation of Birth Cohort in Korea study 2008 (NICKs-2008) vol.64, pp.9, 2011, https://doi.org/10.3345/cep.2020.01284
  163. Effect of KRAS and BRAF mutations in metastatic colorectal cancer patients: A systematic review and meta-analysis based on tumor sidedness and KRAS subtypes vol.29, pp.4, 2011, https://doi.org/10.3233/hab-210451
  164. Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018) vol.21, pp.1, 2011, https://doi.org/10.1186/s12885-021-09078-8
  165. Effect of non-curative endoscopic submucosal dissection on short-term outcomes of subsequent surgery for early gastric cancer vol.45, pp.1, 2022, https://doi.org/10.1016/j.asjsur.2021.05.008